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The prion-like protein termed Doppel (Dpl) shows approx. 25% sequence identity with all known prion proteins (PrP). We recently
showed that the cellular PrP is dimeric under native conditions, a finding which was confirmed by the investigation of its crystal
structure. Human PrP further interacts with its cellular receptor, the 37 kDa/67 kDa laminin receptor (LRP/LR). Here we report that
human Doppel fails to interact with (i) itself, (ii) the human 37 kDa/67 kDa LRP/LR, and (iii) the human cellular prion protein (huPrP)
in the yeast two-hybrid system. Our findings suggest that Dpl and PrP are not related or are only marginally related with respect to
their ligand binding behaviour.
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Prion diseases are fatal neurodegenerative disorders which dimers might act as powerful tools to interfere with the prionoccur in man or animals (for review see Refs. [1–3]). Amajor
feature of these diseases is the conversion of the non-
pathogenic, cellular prion protein PrPc into the pathogenic
isoform PrPSc (for review see Ref. [4]). This isoform has a
strong tendency to polymerize forming amyloid aggregates.
Recent publications demonstrated that PrPc shows dimeriza-
tion properties: (i) PrP dimers have been observed as inter-
mediate states during PrP-multimerization [5,6], (ii) the
crystal structure of human PrP reveals a dimeric nature of
the prion protein [7], and (iii) we recently showed that PrP is
dimeric under native conditions, interacts with itself in the
yeast two-hybrid system and in recombinant Semliki Forest
virus (SFV)-transfected BHK cells [8]. Furthermore, anti-
bodies directed against dimeric PrP interfere with PrPSc
propagation in cultured cells [9] and a soluble dimeric PrP
generated by fusion to immunoglobulin Fcg binds PrPSc in
vivo and antagonizes prion disease [10]. Covalently linked0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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Besides the self-interaction of the prion protein, a series of
ligands for the prion protein have been identified. Among
them are protein X [12], the 37 kDa/67 kDa laminin receptor
[13] acting as the cellular receptor for PrPc [14] (for reviews:
see Refs. [15,16]) and proven to be required for PrPSc
propagation in cultured cells [17], as well as HSPGs acting
as co-factors/co-receptors for PrP [18]. Transgenic ectopic
expression of specific antisense LRP RNA in the mouse brain
resulted in a knock-down of the 37 kDa/67 kDa laminin
receptor in the hippocampus and the cerebellum [19].
Recently, a prion-like protein was identified termed
Doppel (Dpl) [20]. Dpl is approx. 25% homologous to
PrP and has a series of common features with normal PrP
(for summary see Table 1). Although both proteins differ in
size (for review, see Ref. [21]), both are processed during
maturation, a process in which signal peptides and signal
sequences become removed. Both proteins are glycosylated
at two C-terminal residues. Whereas PrP reveals three a-
helices and two h-sheets, Doppel encompasses four a-
helices and two h-sheets (see Table 1). Within the Prn-p-
gene defined mutations/polymorphisms exist causing trans-
Table 1
Comparison of the prion protein with its homolog Doppel
Feature Prion proteina Doppel
protein
Universal properties
protein size (human) 253 aa 179 aa [20]
mature form (human) aa 23–230 aa 27–154 [29]
signal peptide/signal
sequence
yes yes [20]
disulfide bridge one two [20]
octarepeat region yes no [20]
copper binding yes yes [22]
glycosylation sites two two [20]
mutations/
polymorphisms
at least 22
(human)
four (human) [37]
structure three a-helices/
two h-sheets
four a-helices/
two h-sheets
(murine) [38]
(human) [39]
pK treatment sensitive (PrPc) sensitive [40]
Expression
during RNA
embryogenesis
yes yes [20]
in the CNS high level low level [20]
PrP0/0 mice no upregulation [20]
main local
expression
brain testis [29]
PrPSc propagation PrPc-dependent Dpl dispensable
[25]
Oxidative stress SOD activity induction of
oxidative stress
markers [41]
Ligands
binding to PrP yes [8] nob
binding to Dpl nob nob
binding to 37 kDa/
67 kDa LRP/LR
yes [13,18] nob
a For PrP citations see Ref. [42].
b Data described in this manuscript.
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Defined mutations within the Prn-d-gene have also been
observed (Table 1). However, their relevance for the devel-
opment of TSEs is speculative. In contrast to PrP, Doppel
lacks the octarepeat region which is responsible for copper
binding. Surprisingly, it was recently shown that Dpl binds
copper via the aB/BV-loop-aC subregion [22]. The proposed
transmembrane region of PrP (aa 106–126) which seems to
have neurotoxic effects is also missing in Dpl [20]. In contrast
to PrP which exhibits one disulfide bridge, Dpl contains four
cystein residues which are able to form two disulfide bridges
[20]. The role of Dpl in prion diseases remains speculative
since expression of Dpl in the CNS of mice did not influence
the development of TSEs [23], its expression is not modified
in scrapie-infected cells and in brains of CJD patients [24] and
Dpl is not required for PrPSc generation and prion disease
progression [25]. Although Doppel and PrP are raft-associ-
ated proteins, they do not seem to share the same membrane
microenvironment [26]. The onset of ataxia and Purkinje cell
loss—originally described as a phenotype for the loss of
function of PrPc in PrP knock-out mice [27]—has beenshown to be a consequence of Dpl expression in the brain
[28]. Doppel is mainly expressed in testis [29] and Dpl
knock-out mice reveal male sterility [30].
Very little is known about the potential binding partners
of Doppel. PrP is able to interact with itself [8] and with the
37 kDa/67 kDa laminin receptor [13], acting as the cellular
receptor for PrPc [14] required for PrPSc propagation in
neuronal cells [17]. A potential direct interaction between
Dpl and PrP has not been investigated so far. Therefore, we
wanted to investigate whether Doppel is able to interact with
itself (i) the prion protein (ii) and the 37 kDa/67 kDa LRP/
LR (iii) employing the yeast two-hybrid system as a
powerful method for the investigation of protein–protein
interactions (for review, see Ref. [31]).
The Dpl27–154 protein failed to interact with GSTD
huPrP23–230 (Fig. 1, row 2). As a control, GST failed also
to interact with Dpl27–154 (Fig. 1, row 1). Dpl27–154
did also not interact with LRP44–295 the cellular recep-
tor for PrP [14] (Fig. 1, row 3), whereas GSTD
huPrP23–230 interacts with its receptor LRP44–295
(Fig. 1, row 5). Dpl27–154 shows also no interaction
with itself in the yeast two-hybrid system (Fig. 1, row 4),
whereas huPrP23–230 interacts with itself in the same
system [8].
In order to exclude the possibility that the failure of
Doppel to interact with PrP, LRP and itself might be due to
the lack of expression in the yeast two-hybrid system, we
investigated whether Dpl is expressed in bait and prey
position. After co-transformation of yeast cells with the bait
plasmid pSH2–1-Dpl27–154 and the prey plasmid pJG4–5-
Dpl27–154, we analyzed the crude lysate of the yeast cells by
Western blotting employing a polyclonal anti-Dpl antibody.
We observedmolecular weights of approx. 21 kDa for the bait
and approx. 36 kDa for the prey protein (Fig. 2), which is in
good harmony with the expected molecular weights of 21
kDa (lexA-DNA-binding domain: 7 kDa plus Dpl27–154:
14 kDa) and 36 kDa (acidic activation domain B42: 22 kDa
plus Dpl27–154: 14 kDa). The band at approx. 70 kDa might
be due to a cross-reactivity of the anti-Dpl-antibody. These
data demonstrate that the failure of Doppel to interact with
itself, the prion protein and the LRP/LR is not due to the lack
of Doppel expression.
Our finding that Dpl failed to interact with itself in the
yeast two-hybrid system was predicted by modelling the
potential Dpl and PrP interaction interfaces suggesting that
Dpl might fail to dimerize [32]. The model states that PrP
dimerization might take place via a h-hairpin structure
located between aa 119 and 128 of PrP, a non-polar region
which is lacking in the Dpl protein suggesting that
dimerization here might take place via another domain.
We have recently shown that one major interaction domain
for the PrP/PrP interaction represents the octarepeat region
[8], which is highly conserved in different mammalian
species [33]. One feature of the octarepeat region is the
binding of copper [34], which might be triggering a
copper-mediated protein–protein interaction. Copper-in-
Fig. 1. Interaction study of the prion-like protein Dpl. HuDpl27–154 in bait-position (rows 1–4) was co-expressed with GST (row 1), GSTDhuPrP23–230
(row 2), LRP44–295 (row 3) and Dpl27–154 (row 4) in prey-position of the yeast two-hybrid system. For positive control GSTDhuPrP23–230 in bait
position and LRP44–295 in prey position was co-expressed (row 5) [13,18]. Interactions were detected by the h-galactosidase reporter system. We amplified
the Dpl27–154 (the mature form of Doppel [29]) encoding cDNA by RT-PCR using oligodeoxyribonucleotides flanking the Dpl-sequence and introducing
EcoRI (5V) and SalI (3V) restriction sites from mRNA isolated from cultivated HeLa cells. The PCR-product was cloned into the vector pSH2-1 via EcoRI and
SalI restriction sites resulting in pSH2–1-Dpl27–154. The Dpl27–154 encoding cDNA was excised from pSH2-1-via EcoRI and SalI and subcloned into
pJG4–5 restricted with EcoRI and XhoI resulting in pJG4–5-Dpl27–154. All plasmids were confirmed by didesoxy sequencing. The construction of pSH2–
1-GST, pSH-2–1-GSTDhuPrP23–230 and pJG4–5-LRP44–295 was described previously [13]. The different bait and the prey plasmids as well as the
reporter plasmid pSH18–34 (lacZ) were co-transformed into EGY48 yeast cells and transformants were tested in a h-galactosidase assay as described [8,18].
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disease [35]. This octarepeat region is missing within the
Dpl protein and therefore metal-induced dimerization is
unlikely. A hypothetical Dpl/Dpl interaction might take
place via the core region of the protein since human PrP/
PrP interactions also take place via the PrP90–230 region
[8]. However, results from the prion protein cannot be
transferred to Doppel due to a more rigid structure of the
latter which might result from two disulfide bridges. In
addition, structural changes, e.g. domain swapping ob-
served in the dimeric crystal structure of PrP [7] should
be more hampered by the two disulfide bridges in the Dpl
protein. Dimeric forms of Dpl did not appear under
denaturing conditions, e.g. during analysis of the expres-
sion whereas dimeric forms of PrP were observed when
PrP was expressed in neuroblastoma cells and in scrapie-
infected hamster brains [36]. In contrast to PrP [8], Dpl
indeed failed to interact with itself in the yeast two-hybrid
system suggesting that both proteins have a different self-
interacting behaviour probably due to significant structural
differences.
No interaction partners of Doppel have been identified
so far. In contrast, a series of interaction partners for the
prion protein have been described (for review, see Ref.
[15]). One of which represents the 37 kDa/67 kDa laminin
receptor which acts as the cell surface receptor for the
cellular prion protein [14]. A hypothetical direct interaction
between Doppel and the prion protein has not been
described. The lack of interaction between Doppel andPrP as well as with 37 kDa/67 kDa LRP/LR together with
the findings that (i) expression of Doppel in the CNS of
mice does not modulate TSEs [23], (ii) Dpl expression is
not modified in scrapie-infected cells and in the brain of
CJD patients [24], and (iii) Dpl is dispensable for prion
disease progression and PrPSc generation [25] suggests that
Doppel might not play a crucial role in the life cycle of
prions.
We excluded that the failure of Doppel to interact with
itself, the prion protein and LRP/LR might be due to the
lack of Doppel expression in the yeast two-hybrid system,
since we proved Dpl expression in both prey and bait
position. We assume that structural differences between
Dpl and PrP might account for the different interaction
behaviours of both proteins. Although our data do not
support an essential role of the Doppel protein in prion
diseases, further studies are required to investigate in more
detail a possible contribution of Dpl in transmissible spongi-
form encephalopathies.Acknowledgements
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